An MUHC team evaluates a new saliva-based HIV test to speed up detectionMay 06, 2008The usual waiting period for the results of a HIV test can seem like an eternity, especially in emergency situations where results are needed immediately. Also it requires a blood sample, which is invasive and often painful. Recognizing the urgent need for a faster and less invasive diagnostic method, Dr. Nitika Pant Pai, from Marina Klein's research team at the MUHC has just finished testing a new saliva-based test that gives results in approximately 20 minutes! She describes her findings in an article that will appear in the May 6th, 2008 issue of PLoS Medicine (Public Library of Science, an open access publication). To overcome the barriers associated with blood collection, which is off-putting for many patients, this new test is based on oral mucosal transudate (OMT), a fluid that is secreted at the base of the gums before it becomes saliva. In fact, the level of antibodies in OMT is comparable to that of blood plasma, making it an excellent sample. To test this innovative technique under real world conditions, especially in vulnerable pregnant women, Dr. Pant Pai carried out clinical trials in the labor ward of the Mahatma Gandhi Institute of Medical Sciences, Sevagram, Maharastra, India. "In such cases, it is vital to determine the HIV status of the mother very quickly to prevent transmission to the child during delivery. Many Indian women do not receive prenatal care and therefore do not get tested for HIV during pregnancy. Testing in the labor ward is the last chance to prevent HIV transmission to the newborn baby. Also Indian patients often refuse blood collection, while saliva collection poses no problem," explained Dr. Pant Pai.
This is the kind of situation when this innovative test reveals all its potential. In the study, 1222 mothers were tested for HIV in the labor ward using both saliva and blood samples. The results from both kinds of tests corresponded in 100 percent of cases. In addition, use of the saliva test in the labor ward helped identified several HIV infected women who were unaware of the HIV status. These women received treatments to reduce the chance of HIV infection in the newborn babies. This is an incredible piece of evidence for the accuracy and ease of execution of this new oral test. The underlying method, called immunochromatography, is the same as for pregnancy tests. This technique aggregates the antibodies contained in the sample of oral mucosal transudate with the antigens (molecules recognized as enemy by the immune system) contained in the test. The OMT is simply collected on a stick, which is also similar to the one used in a pregnancy test, and then placed in a small tube containing a special solution. Between 20 and 40 minutes later a purple line will appear at the top of the stick if the result is positive. "Rapid saliva tests are not in use yet in Canada, as they are met here with a lot of skepticism," Dr. Pant Pai acknowledged. "However, their efficacy has now been demonstrated for all subtypes of HIV-1 and HIV-2." These tests could become highly useful for vulnerable or at-risk people who are not always given adequate medical follow-up. A rapid, low-cost test would therefore reduce the number of patients who are unaware of their HIV status. Long-term, this research will hopefully pave the way to a more widespread use of rapid oral fluid HIV tests to prevent mother to child transmission of the HIV virus. It may also pave the way for an over-the-counter test for home use. McGill University Health Centre | |||||||||||||||||||||
|
Related HIV Test Current Events and HIV Test News Articles Doctors failing to diagnose HIV early in UK Africans Doctors are missing valuable opportunities to diagnose HIV in Africans living in the UK, with serious consequences for their long term health, according to research funded by the Wellcome Trust. State laws may limit implementation of CDC's recommendations for routine HIV testing A new study concludes that routine testing for HIV recommended by the Centers for Disease Control (CDC) may violate many state laws. Widely used hepatitis B drug spurs HIV drug resistance A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. European research yields guidelines for treatment of HIV-positive pregnant women and infants New guidelines for the treatment of HIV-positive women and children are emerging from European research. The guidelines, aimed at reducing mother-to-child transmission of HIV, are to be published on 28 June 2002 as a supplement to the journal AIDS. A comparable set of guidelines for paediatric patients will be published in July 2002. Both reports result from concerted action projects funded by the European Commission's DG Research. "The definition of HIV treatment guidelines that will limit the risk of mother-to-child transmission of the virus is a good example of the benefits of collaborating at European scale", said European Commissioner for Research Philippe Busquin. "HIV kno Kenyan Study Could Help Other African Countries Improve Hiv Blood-transfusion Strategies (p 657) A 1994 study which highlighted the problem of HIV-1 transmission from blood-transfusion programmes in Kenya-and resulted in positive government action-could help other African countries develop safer blood-transfusion strategies. Little support for blood-safety programmes has been provided to less-developed countries over the past decade. The Kenya Ministry of Health did a collaborative multicentre assessment with Robert Janssen and colleagues from the Centres for Disease Control, Atlanta, USA. The aims of this study were to establish the risk of HIV transmission by transfusion in Kenya, to promote awareness of blood safety issues in a country with a mature HIV epidemic, and to identify meth Making sense of sexual risk-taking by gay men Psychological knowledge and understanding can help make sense of recent reports of an increase in unprotected anal intercourse (termed ‘barebacking’) among gay men. This has important implications for health promotion programmes. These are the key messages of a symposium held today, Tuesday 19 December, at The British Psychological Society’s London Conference, held at the Institute of Education. The symposium chair was Dr Adrian Coyle, Department of Psychology, University of Surrey. Dr Michele Crossley, Turner Dental School, University of Manchester, presented her study which evaluated health promotion and HIV prevention materials aimed at gay men. She suggested that simpli INCREASED RISK OF TUBERCULOSIS RECURRENCE IN PEOPLE WITH HIV-1 INFECTION (pp 1470, 1488) People with HIV-1 infection are at an increased risk of recurrent tuberculosis, and could benefit from preventative treatment after the first episode of the disease, concludes research published in this week's issue of THE LANCET. Patients with HIV-1 infection respond well to treatment for active tuberculosis, but whether such patients are at increased risk of disease recurrence after successful treatment is uncertain. As a result, most experts do not recommend more intensive tuberculosis therapy for HIV-1-infected individuals than for uninfected people, and do not recommend prophylaxis after curative treatment. Jean William Pape and colleagues from New York Hospital-Cornell Medical Centre, Should we test for HIV status in pregnant women? Dr Lorraine Sherr, Professor Chris Hudson, and colleagues from several UK and European medical schools, have been studying the way other European countries are handling the problem, and found that the major variations between countries reflect the complexity of the ethics involved. More HIV Test Current Events and HIV Test News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||